Abstract
In this chapter, we start with the origin of nanotechnology and nanomedicine and the definition of nanomedicine in the USA and Europe. The size range of nanomedicine is discussed according to different definitions and regulations, and development of nanomedicine from lab to market is reviewed. Nanomaterials for nanomedicine is divided into two categories of polymer-based and metal-based. A brief explanation of most important nanomaterials including liposome, carbohydrates, gold, silver, and iron oxide in drug delivery and release, sensing and imaging are given. Nanomedicines already showed their potential and are promising to cure cancer, neurodegenerative disorders including NeuroHIV, Alzheimer’s, and Parkinson’s.
This is a preview of subscription content, log in via an institution to check access.
References
Feynman R. There’s plenty of room at the bottom, American Physical Society. Pasadena: Caltech; 1959.
Taniguchi N. On the basic concept of nanotechnology. In: International Conference on Product Engineering. Tokyo: Japan Society of Precision Engineering; 1974. p. 18–23.
Nanomedicine: grounds for optimism, and a call for papers. The Lancet. 2003;362(9385):673.
Nikkhah-Moshaie R, Kaushik A, Jayant RD, Bhardwaj V, Nair M. TEM investigation of nanocarriers distribution in mice brain. Microsc Microanal. 2016;22(S3):1173–2.
Roco MC. National nanotechnology initiative: past, present, future. In: Goddard WA, Brenner DW, Lyshevski SE, Iafrate G, editors. Handbook on nanoscience, engineering and technology. 2nd ed. London: Taylor and Francis; 2007. p. 26.
Litzinger DC, Buiting AMJ, Rooijen NV, Huang L. Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. Biochim Biophys Acta. 1994;1190(1):99–107.
Nanospectra Biosciences, Inc. Pilot study of Aurolase (tm) therapy in refractory and/or current tumors of the head and neck; 2009.
Pillai G. Nanomedicine for cancer therapy: an update of FDA approved and those under various stages of development. SOJ Pharm Pharm Sci. 2014;1(2):13.
European Commission. Commission recommendation of XXX on the definition of nanomaterial. Brussels: European Commission; 2011. p. 6.
European Union. Regulation (EU) No 528/2012 of the European Parliament and of the council of 22 May 2012 concerning the making available on the market and use of biocidal products, vol. L 167/1. Luxembourg: Office of the European Union; 2012.
European Science Foundation. Nanomedicine, An ESF—European Medical Research Councils (EMRC) Forward Look report. Strasbourg cedex, France: ESF; 2005. p. 7.
Steinhoff G. Regenerative medicine from protocol to patient. 2nd ed. Dordrecht: Springer; 2013.
Venkatraman SS, Ma LL, Natarajan JV, Chattopadhyay S. Polymer- and liposome-based nanoparticles in targeted drug delivery. Front Biosci. 2010;S2:801–14.
Vashist A, Kaushik A, Vashist A, Jayant RD, Tomitaka A, Ahmad S, Gupta YK, Nair M. Recent trends on hydrogel based drug delivery systems for infectious diseases. Biomater Sci. 2016;4:1535–53.
Bozzuto G, Molinari A. Liposomes as nanomedical devices. Int J Nanomedicine. 2015;10:975–99.
Bhardwaj V, Srinivasan S, McGoron AJ. Efficient intracellular delivery and improved biocompatibility of colloidal silver nanoparticles towards intracellular SERS immuno-sensing. Analyst. 2015;140(12):3929–34.
Srinivasan S, Bhardwaj V, Nagasetti A, Fernandez-Fernandez A, McGoron AJ. Multifunctional surface-enhanced Raman spectroscopy-detectable silver nanoparticles for combined photodynamic therapy and pH-triggered chemotherapy. J Biomed Nanotechnol. 2016;12(12):2202–19.
Kaushik A, Jayant RD, Nikkhah-Moshaie R, Bhardwaj V, Roy U, et al. Magnetically guided central nervous system delivery and toxicity evaluation of magneto-electric nanocarriers. Sci Rep. 2016;6:25309.
Kaushik A, Nikkhah-Moshaie R, Bhardwaj V, Sinha R, Alturi V, et al. Investigation of ac-magnetic field stimulated nanoelectroporation of magneto-electric nano-drug-carrier inside CNS cells. Sci Rep. 2017;7:45663.
Kaushik A, Jayant RD, Sagar V, Nair M. The potential of magneto-electric nanocarriers for drug delivery. Expert Opin Drug Deliv. 2014;11(10):1635–46.
Jain PK, Huang X, El-Sayed IH, El-Sayed MA. Noble metal at nanoscale: optical and photothermal properties and some applications in imaging, sensing, biology and medicine. Acc Chem Res. 2008;41(12):1578–86.
Etheridge ML, Campbell SA, Erdman AG, Haynes CL, Wolf SM, et al. The big picture on nanomedicine: the state of investigational and approved nanomedicine products. Nanomedicine. 2013;9(1):1–14.
Kaushik A, Jayant RD, Nair M. Advancements in nano-enabled therapeutics for neuroHIV management. Int J Nanomedicine. 2016;11:4317–25.
Jayant RD, Sosa D, Kaushik A, Atluri V, Vashist A, et al. Current status of non-viral gene therapy for CNS disorders. Expert Opin Drug Deliv. 2016;13(10):1433–45.
Nair M, Jayant RD, Kaushik A, Sagar V. Getting into the brain: potential of nanotechnology in the management of NeuroAIDS. Adv Drug Deliv Rev. 2016;103:202–17.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Bhardwaj, V., Nikkhah-Moshaie, R. (2017). Nanomedicine. In: Kaushik, A., Jayant, R., Nair, M. (eds) Advances in Personalized Nanotherapeutics . Springer, Cham. https://doi.org/10.1007/978-3-319-63633-7_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-63633-7_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-63632-0
Online ISBN: 978-3-319-63633-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)